Aclarion, Inc. (ACONW) stock
ACONWNasdaqServices-Medical LaboratoriesFiscal year ends December 31Also trades as ACON
$0.02+0.00 (0.00%)
Close on Oct 30, 2026Market cap $5.62MP/E –Yield –
Aclarion gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
Aclarion's gross profit for the twelve months ending Jun 30, 2026 was $18.22K. For fiscal 2025 it was $6.83K. The highest annual figure on record is $6.83K in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.83K | – |
| FY2024 | Dec 31, 2024 | -$38.93K | – |
| FY2023 | Dec 31, 2023 | -$324 | – |
| FY2022 | Dec 31, 2022 | -$4.85K | – |
| FY2021 | Dec 31, 2021 | -$8.88K | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.30K | +61.4% |
| Q1 FY2026 | Mar 31, 2026 | $3.75K | – |
| Q4 FY2025 | Dec 31, 2025 | $1.79K | – |
| Q3 FY2025 | Sep 30, 2025 | $4.39K | – |
| Q2 FY2025 | Jun 30, 2025 | $5.14K | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.49K | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.32K | – |
| Q3 FY2024 | Sep 30, 2024 | -$6.93K | – |
| Q2 FY2024 | Jun 30, 2024 | -$12.32K | – |
| Q1 FY2024 | Mar 31, 2024 | -$9.36K | -216.8% |
| Q4 FY2023 | Dec 31, 2023 | -$5.62K | -207.4% |
| Q3 FY2023 | Sep 30, 2023 | -$493 | -141.3% |
| Q2 FY2023 | Jun 30, 2023 | -$2.23K | – |
| Q1 FY2023 | Mar 31, 2023 | $8.02K | – |
| Q4 FY2022 | Dec 31, 2022 | $5.23K | -1.6% |
| Q3 FY2022 | Sep 30, 2022 | $1.19K | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.24K | – |
| Q3 FY2021 | Sep 30, 2021 | -$5.22K | – |
| Q2 FY2021 | Jun 30, 2021 | $5.32K | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.74K | – |